Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06839391 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 21, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Benha University
124 trials monitored
See 3 trials at risk
evaluate the efficacy of hyaluronidase in different doses as an adjuvant to bupivacaine in ultrasound-guided TAB block during CS
Trial Details
NCT Number NCT06839391
Lead Sponsor Benha University
Conditions
(from sponsor)		 Tab Block Qaulity
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov